Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 14, 2018

SELL
$17.08 - $25.64 $561,932 - $843,556
-32,900 Closed
0 $0
Q4 2017

Feb 13, 2018

SELL
$21.47 - $27.8 $298,433 - $386,420
-13,900 Reduced 29.7%
32,900 $811,000
Q2 2017

Aug 19, 2019

SELL
N/A
-1,600 Reduced 3.31%
46,800 $1.27 Million
Q1 2017

Aug 13, 2019

BUY
N/A
48,400
48,400 $1.44 Million

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $255M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.